Literature DB >> 27341307

Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.

Kung-Kai Kuo1,2, King-Teh Lee1, Ker-Kong Chen3, Ya-Han Yang1,4,2, Ying-Chu Lin3, Ming-Ho Tsai4, Kenly Wuputra4, Yen-Liang Lee5, Chia-Chen Ku4, Hiroyuki Miyoshi6, Yukio Nakamura7, Shigeo Saito8, Chun-Chieh Wu9, Chee-Yin Chai9, Richard Eckner10, Chen-Lung Steve Lin1,4, Sophie S-W Wang11,2, Deng-Chyang Wu11,2,12,13, Chang-Shen Lin4,14, Kazunari K Yokoyama4,2,12,15,16,17.   

Abstract

The network of stemness genes and oncogenes in human patient-specific reprogrammed cancer stem cells (CSCs) remains elusive, especially in liver cancer. HepG2-derived induced pluripotent stem cell-like cells (HepG2-iPS-like cells) were generated by introducing Yamanaka factors and the knockdown vector shTP53. They exhibited features of stemness and a higher tumorigenesis after xenograft transplantation compared with HepG2 cells. The cancerous mass of severe combined immunodeficiency (SCID) mice derived from one colony was dissected and cultured to establish reprogrammed HepG2-derived CSC-like cells (designated rG2-DC-1C). A single colony exhibited 42% occurrence of tumors with higher proliferation capacities. rG2-DC-1C showed continuous expression of the OCT4 stemness gene and of representative tumor markers, potentiated chemoresistance characteristics, and invasion activities. The sphere-colony formation ability and the invasion activity of rG2-DC-1C were also higher than those of HepG2 cells. Moreover, the expression of the OCT4 gene and the c-JUN oncogene, but not of c-MYC, was significantly elevated in rG2-DC-1C, whereas no c-JUN expression was observed in HepG2 cells. The positive-feedback regulation via OCT4-mediated transactivation of the c-JUN promoter and the c-JUN-mediated transactivation of the OCT4 promoter were crucial for promoting cancer development and maintaining cancer stemness in rG2-DC-1C. Increased expression of OCT4 and c-JUN was detected in the early stage of human liver cancer. Therefore, the positive feedback regulation of OCT4 and c-JUN, resulting in the continuous expression of oncogenes such as c-JUN, seems to play a critical role in the determination of the cell fate decision from iPS cells to CSCs in liver cancer. Stem Cells 2016;34:2613-2624.
© 2016 The Authors STEM CELLS published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.

Entities:  

Keywords:  Cancer stem cells; Liver cancer; OCT4; Pluripotency; Positive feedback; Reprogramming; c-JUN

Mesh:

Substances:

Year:  2016        PMID: 27341307     DOI: 10.1002/stem.2447

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  22 in total

1.  MicroRNA-145 sensitizes cervical cancer cells to low-dose irradiation by downregulating OCT4 expression.

Authors:  Siqi Yan; Xiangjun Li; Qiao Jin; Jun Yuan
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

2.  MiR-422a weakened breast cancer stem cells properties by targeting PLP2.

Authors:  Yanmei Zou; Yuandong Chen; Shuo Yao; Guangrui Deng; Dian Liu; Xun Yuan; Shunfang Liu; Jie Rao; Huihua Xiong; Xianglin Yuan; Shiying Yu; Feng Zhu; Yihua Wang; Hua Xiong
Journal:  Cancer Biol Ther       Date:  2018-03-30       Impact factor: 4.742

3.  Pluripotency Stemness and Cancer: More Questions than Answers.

Authors:  Jiří Hatina; Michaela Kripnerová; Zbyněk Houdek; Martin Pešta; Filip Tichánek
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Aryl hydrocarbon receptor blocks aging-induced senescence in the liver and fibroblast cells.

Authors:  Ana Nacarino-Palma; Eva M Rico-Leo; Judith Campisi; Arvind Ramanathan; Francisco J González-Rico; Claudia M Rejano-Gordillo; Ana Ordiales-Talavero; Jaime M Merino; Pedro M Fernández-Salguero
Journal:  Aging (Albany NY)       Date:  2022-05-26       Impact factor: 5.955

Review 5.  Inflammation Shapes Stem Cells and Stemness during Infection and Beyond.

Authors:  Stella Michael; Charis Achilleos; Theofano Panayiotou; Katerina Strati
Journal:  Front Cell Dev Biol       Date:  2016-11-02

Review 6.  The evolving concept of liver cancer stem cells.

Authors:  Kouki Nio; Taro Yamashita; Shuichi Kaneko
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

Review 7.  Cancer cell reprogramming to identify the genes competent for generating liver cancer stem cells.

Authors:  Kenly Wuputra; Chang-Shen Lin; Ming-Ho Tsai; Chia-Chen Ku; Wen-Hsin Lin; Ya-Han Yang; Kung-Kai Kuo; Kazunari K Yokoyama
Journal:  Inflamm Regen       Date:  2017-05-18

8.  Dioxin Receptor Adjusts Liver Regeneration After Acute Toxic Injury and Protects Against Liver Carcinogenesis.

Authors:  Nuria Moreno-Marín; Eva Barrasa; Antonio Morales-Hernández; Beroé Paniagua; Gerardo Blanco-Fernández; Jaime M Merino; Pedro M Fernández-Salguero
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

9.  Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines.

Authors:  Yuki Haga; Tatsuo Kanda; Masato Nakamura; Shingo Nakamoto; Reina Sasaki; Koji Takahashi; Shuang Wu; Osamu Yokosuka
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

10.  Deletion of Jdp2 enhances Slc7a11 expression in Atoh-1 positive cerebellum granule cell progenitors in vivo.

Authors:  Chia-Chen Ku; Kenly Wuputra; Kohsuke Kato; Jia-Bin Pan; Chia-Pei Li; Ming-Ho Tsai; Michiya Noguchi; Yukio Nakamura; Chung-Jung Liu; Te-Fu Chan; Ming-Feng Hou; Shigeharu Wakana; Yang-Chang Wu; Chang-Shen Lin; Deng-Chyang Wu; Kazunari K Yokoyama
Journal:  Stem Cell Res Ther       Date:  2021-06-29       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.